How many orders did MedPal’s New Health private prescription clinic dispense on 5 October 2026?

MedPal said its New Health private prescription clinic dispensed more than 2,300 orders in a single day on Monday 5 October 2026, with about £0.3m total order value.

MedPal AI — TickStock

Timeline

MedPal AI

18 stories · updated 4d ago

MedPal AI confirms no equity raise planned as it seeks working capital facility

09:22, 8 Oct 2026

MedPal AI revenue run rate boosted by repeat orders

08:33, 6 Oct 2026

MedPal AI shares soar after August run rate update

08:59, 7 Sept 2026 · Updated 11:16, 7 Sept

FDA clears Mounjaro for heart protection, MedPal flags market boost

16:17, 1 Sept 2026

UK authorises second oral GLP-1 pill as MedPal eyes wider funnel

15:03, 11 Aug 2026

MedPal AI hits £8.6m revenue run rate after record July

08:00, 4 Aug 2026

MedPal buys eMARx to complete care home health platform

09:42, 20 Jul 2026

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

07:53, 3 Jul 2026

MedPal AI opens largest robotic dispensing facility in Runcorn with NHS approval

10:06, 1 Jul 2026

MedPal AI launches Juno agentic health companion on Anthropic and DigitalOcean stack

07:45, 18 Jun 2026

UK approval for first oral GLP-1 weight-loss pill will open private market opportunity, MedPal tells investors

07:47, 12 Jun 2026

MedPal AI shares rise after company boasts best month to date

14:42, 1 Jun 2026 · Updated 15:44, 1 Jun

MedPal AI posts first revenues as pharmacy run rate tops £5m

08:35, 29 May 2026

MedPal AI launches New Health sub-brand for GLP-1s and peptides with £1.3m marketing push

08:42, 20 May 2026

MedPal AI buys Remedi Runcorn pharmacy, adding a £10m patient book

09:39, 29 Apr 2026

MedPal AI raises £3m to fund GLP‑1 clinic roll‑out

08:57, 17 Apr 2026

MedPal launches Health OS to close the wearable-to-prescription loop in the UK

15:38, 8 Apr 2026

MedPal AI launches MedPal weight loss blood test for GLP‑1 users

14:25, 20 Mar 2026

More in Healthcare Services

Healthcare Services

hVIVO appoints Angela Hildreth as Chief Financial Officer

08:14, 12 Oct 2026

Healthcare Services

Bunzl acquires UK care home products distributor Blueleaf Care

09:11, 8 Oct 2026

Medtech & Diagnostics

Cambridge Cognition joins NHS study on earlier Alzheimer's diagnosis

08:32, 6 Oct 2026

Biotech

Health & Bio Today: Fusion Antibodies refreshes platform after margin turnaround, Molecule Group

17:03, 5 Oct 2026

Retail

Vulcan Two Group rebrands as Molecule Group

10:21, 5 Oct 2026

Medtech & Diagnostics

IXICO presents Parkinson's imaging research at European conference

10:13, 1 Oct 2026

Biotech

Imaging Biometrics builds US pipeline, rebrands core platform as IB Vista

08:54, 1 Oct 2026

Healthcare Services

PHP rental growth outpaces guidance as joint venture deals progress

08:42, 1 Oct 2026

Biotech

GENinCode revenue halves as NHS cutbacks bite

11:10, 29 Sept 2026

Medtech & Diagnostics

Ondine partners with Mela Solutions to speed NHS Steriwave adoption

08:57, 29 Sept 2026

GDP & Growth

CVS Group lifts EBITDA as Australia expansion accelerates

08:52, 24 Sept 2026

MedPal AI plc is a digital health and pharmacy group operating NHS distance selling pharmacies, a GLP-1 weight management clinic, a care home pharmacy supply business, and Juno, an AI health companion.

Sector: Healthcare Services
Market: AIM

Insight

What was MedPal AI’s cash and cash equivalents at 28 February 2026?

MedPal AI reported cash and cash equivalents at the period end on 28 February 2026 of £4.189m.

Updated 10 Oct 2026

Insight

Did MedPal agree to any new equity fundraising after the £5m placing completed on 24 September?

No. MedPal stated that no equity fundraising has been agreed and none is planned following the £5m placing completed on 24 September.

Updated 10 Oct 2026

Insight

Who is MedPal AI's founder and chief executive officer?

Jason Drummond is MedPal AI's Founder and Chief Executive Officer.

Updated 10 Jun 2026

Insight

How is MedPal AI characterised?

MedPal AI is characterised as a micro-cap, which may affect liquidity and the availability of public information.

Updated 10 Jun 2026

Insight

What was the purpose of MedPal’s general meeting described in the latest update?

MedPal said the general meeting is housekeeping to restore share allotment authorities exhausted after the 30 March AGM permissions and to allow warrants to be issued as announced on 6 October.

Updated 10 Oct 2026

Identifiers

Ticker: MPAL
Market: AIM
ISIN: GB00BTRC7N37
LEI: 984500EDP8B0A14CBA61

Learn more on:

GLEIF

Timeline

MedPal AI

MedPal AI confirms no equity raise planned as it seeks working capital facility

MedPal AI revenue run rate boosted by repeat orders

MedPal AI shares soar after August run rate update

FDA clears Mounjaro for heart protection, MedPal flags market boost

UK authorises second oral GLP-1 pill as MedPal eyes wider funnel

MedPal AI hits £8.6m revenue run rate after record July

MedPal buys eMARx to complete care home health platform

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

MedPal AI opens largest robotic dispensing facility in Runcorn with NHS approval

MedPal AI launches Juno agentic health companion on Anthropic and DigitalOcean stack

UK approval for first oral GLP-1 weight-loss pill will open private market opportunity, MedPal tells investors

MedPal AI shares rise after company boasts best month to date

MedPal AI posts first revenues as pharmacy run rate tops £5m

MedPal AI launches New Health sub-brand for GLP-1s and peptides with £1.3m marketing push

MedPal AI buys Remedi Runcorn pharmacy, adding a £10m patient book

MedPal AI raises £3m to fund GLP‑1 clinic roll‑out

MedPal launches Health OS to close the wearable-to-prescription loop in the UK

MedPal AI launches MedPal weight loss blood test for GLP‑1 users

More in Healthcare Services

hVIVO appoints Angela Hildreth as Chief Financial Officer

Bunzl acquires UK care home products distributor Blueleaf Care

Cambridge Cognition joins NHS study on earlier Alzheimer's diagnosis

Health & Bio Today: Fusion Antibodies refreshes platform after margin turnaround, Molecule Group

Vulcan Two Group rebrands as Molecule Group

IXICO presents Parkinson's imaging research at European conference

Imaging Biometrics builds US pipeline, rebrands core platform as IB Vista

PHP rental growth outpaces guidance as joint venture deals progress

GENinCode revenue halves as NHS cutbacks bite

Ondine partners with Mela Solutions to speed NHS Steriwave adoption

CVS Group lifts EBITDA as Australia expansion accelerates

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer